Gliclazide Modified Release Tablet Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Gliclazide Modified Release Tablets are oral antidiabetic medicines used for the management of Type 2 Diabetes Mellitus. The modified-release formulation is designed to provide gradual and sustained release of Gliclazide, helping maintain stable blood glucose control throughout the day. Genliva Wellness LLP is a trusted Gliclazide Modified Release Tablet Manufacturer in India offering high-quality diabetic care formulations.

The medicine is widely prescribed for adults with Type 2 diabetes when blood sugar levels cannot be adequately controlled through diet and exercise alone. Genliva Wellness LLP is also a reliable Gliclazide Modified Release Tablet Exporter from India supplying quality pharmaceutical products to international healthcare markets.

Gliclazide Modified Release Tablets are commonly included in long-term diabetes treatment programs due to their sustained glucose-lowering action and convenient dosing regimen. The product forms part of our specialized range of Type 2 Diabetes Management Medicines.

Gliclazide Modified Release Tablets are formulated to provide sustained blood glucose control throughout the day.

Contains Gliclazide as the active ingredient
Modified-release tablet formulation
Promotes insulin secretion from pancreatic beta cells
Provides gradual and sustained drug release
Supports long-term glycemic management

Gliclazide Modified Release Tablets are used in the treatment and management of diabetes-related conditions.

Type 2 Diabetes Mellitus
Elevated blood glucose levels
Long-term diabetes management
Glycemic control support
Adjunct to diet and exercise
Adult diabetic care

Gliclazide Modified Release Tablets help maintain consistent blood glucose control with prolonged therapeutic action.

Supports sustained glucose management
Helps reduce blood sugar fluctuations
Promotes effective insulin release
Convenient once-daily dosing in many treatment plans